chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaccination site erythema, Vaccination site inflammation, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Burning; Redness and inflammation at the injection site; Redness and inflammation at the injection site; Itching; This is a spontaneous report from a contactable physician, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 23Mar2021 at 15:15 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included mild COPD, PCOS, cervical dysplasia and HPV positive. The patient was allergic to tape. Concomitant medications oral contraceptives included and paracetamol (MANUFACTURER UNKNOWN) if necessary. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 31Mar2021, the patient underwent COVID-19 PCR test and the result was negative. On 31Mar2021, the patient experienced redness and inflammation at the injection site. It was itching and burning. It appeared on day 8 post vaccination. It was reported that it seems a delayed toxicity. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the redness and inflammation at the injection site, itching and burning was resolving at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: Worsened vertigo; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955), via an unspecified route of administration in the left arm on 31Mar2021 at 13:30 (at the age of 31-years-old), as a single dose for COVID-19 immunisation. Medical history included bipolar disorder, post-traumatic stress disorder (PTSD), mild social anxiety, tendinitis in both feet and sciatica on the right and left side. The patient did not have any allergies to medications, food or other products. Concomitant medications included quetiapine fumarate (SEROQUEL) 300mg for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204), via an unspecified route of administration in the left arm on 10Mar2021 at 13:45 (at the age of 31-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 10:00, the patient experienced bad vertigo and can barely walk. It was reported that the vertigo was worsened over last 24 hours. The patient did not receive any treatment for the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event vertigo was not resolved at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Lymphadenopathy, Pyrexia
Clinical narrative: fever of 100.2; swollen Lymph Node on left clavice; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6205), via an unspecified route of administration in the left arm on 30Mar2021 at 07:45 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes, hypertension and arthritis. Concomitant medications included nifedipine (MANUFACTURER UNKNOWN), HCTZ (Hydrochlorothiazide) (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN), aspirin (MANUFACTURER UNKNOWN) and rosuvastatin (MANUFACTURER UNKNOWN). The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EM9809) via an unspecified route of administration in the left arm on 09Mar2021 at 17:45 (at the age of 65-year-old) as a single dose for COVID-19 immunisation.  The patient previously received niacin (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), Oseltamivir (TAMIFLU) and exemestane (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 30Mar2021 at 22:00, the patient experienced swollen lymph node on left clavicle which appeared prominently at night after receiving the second dose. On 31Mar2021 at 04:30, the patient had a fever of 100.2 which lasted for approximately 24 hours. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events swollen lymph node on left clavicle and fever of 100.2. The clinical outcomes of the events swollen lymph node on left clavicle was resolved on an unknown date in 2021, while that of fever of 100.2 was resolved on 01Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Breast mass, Breast pain, Breast swelling, SARS-CoV-2 test
Clinical narrative: Extreme amount of pain in both breasts; swollen and full of lumps; swollen and full of lumps; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot Number: unknown) via an unspecified route of administration in the left arm on 11Mar2021 at 12:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included tetanus vaccine (MANUFACTURER UNKNOWN) for an unknown indication received on 25Feb2021, atorvastatin (MANUFACTURER UNKNOWN) for an unknown indication and levothyroxine sodium (SYNTHROID) for an unknown indication received within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was tested for COVID-19. The patient received other vaccines within four weeks prior to the vaccination. On 13Mar2021 at 12:00 the patient experienced extreme amount of pain in both breasts and they were swollen and full of lumps. The patient reported as extreme amount of pain in both breasts for ten days following the first shot and any amount of movement caused pain and they were swollen and full of lumps that were not normally there for ten full days, which started on day 2 post shot. The patient underwent nasal swab COVID-19 PCR virus test on 22Mar2021 and was tested negative. The patient did not receive any treatment for the events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care'.  The clinical outcome of extreme amount of pain in both breasts, swollen breasts and breast lumps were resolving.    No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Mild tremors in muscle around sight of injection; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the arm left on 30Mar2021 at 18:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), aripiprazole (ABILIFY) and propranolol (MANUFACTURER UNKNOWN) received within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 2000 the patient experienced mild tremors in muscle around sight of injection. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of mild tremors in muscle around sight of injection was not recovered.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: Extreme blurry vision; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 12:00 as a single dose (at the age of 56-years-old) for COVID-19 immunisation. The medical history included loss of ability to read as he had before receipt of vaccination. The patient did not receive any concomitant medications. The patient had known allergies to morphine. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. On 01Apr2021 at 06:30, the patient experienced extreme blurry vision. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events extreme blurry vision was not resolved at the time of this report.  No follow-up attempts are needed; information about lot number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Paraesthesia, Pruritus, Somnolence, Vaccination site mass
Clinical narrative: left arm itchy; injection site big bump; painful; extra tired; slept more than usual; tingling in the left arm all over; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Mar2021 at 11:00 (at the age of 32-years-old) as a single dose for COVID-19 immunization. Medical history included hashimoto's disease, acid reflux and knee surgery (on right knee). The patient was allergic to dust, pollen, gluten and mold allergy that caused hay fever. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), clonidine (MANUFACTURER UNKNOWN) and spironolactone (SPIROLACTON). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 06:00, the patient had "COVID arm" syndrome and had left arm itchy, injection site felt like a big bump in arm (vaccination site lump) and felt quite painful when pressed, extra tired and slept more than usual and had tingling arm all over. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events left arm itchy, injection site big bump in arm (vaccination site lump) and quite painful when pressed, extra tired and slept more than usual and had tingling arm all over were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: left arm itchy; injection site big bump; painful; extra tired; slept more than usual; tingling in the left arm all over; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Mar2021 at 11:00 (at the age of 32-years-old) as a single dose for COVID-19 immunization. Medical history included hashimoto's disease, acid reflux and knee surgery (on right knee). The patient was allergic to dust, pollen, gluten and mold allergy that caused hay fever. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included pantoprazole (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), clonidine (MANUFACTURER UNKNOWN) and spironolactone (SPIROLACTON). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 06:00, the patient had "COVID arm" syndrome and had left arm itchy, injection site felt like a big bump in arm (vaccination site lump) and felt quite painful when pressed, extra tired and slept more than usual and had tingling arm all over. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events left arm itchy, injection site big bump in arm (vaccination site lump) and quite painful when pressed, extra tired and slept more than usual and had tingling arm all over were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Arthralgia, Back pain, Cough, Decreased appetite
Clinical narrative: Slept 24 hours off and on; Slept 24 hours off and on; knees, back, shoulders, neck and arms hurt badly; back, shoulders, neck and arms hurt badly; neck and arms hurt badly; arms hurt badly; Felt like I had to vomit but couldn't; No taste of food; No appetite; Headache; Dizziness; Coughing; This is a spontaneous report from a contactable consumer, the patient. A 68-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 24Mar2021 at 14:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetic, shellfish allergy and COVID-19. Concomitant medication included paracetamol (TYLENOL A) for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in the left arm on 03Mar2021 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 03:00, the patient slept 24 hours off and on and also experienced knees, back, shoulders, neck and arms hurt badly. The patient felt like she had to vomit but couldn't and also experienced no taste of food, no appetite, headache, dizziness and coughing. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events slept 24 hours off and on, knees, back, shoulders, neck and arms hurt badly, felt like to vomit, no taste of food, no appetite, headache, dizziness and coughing was recovered after 3 and half days.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Hypersomnia, Neck pain, Pain in extremity
Clinical narrative: Slept 24 hours off and on; Slept 24 hours off and on; knees, back, shoulders, neck and arms hurt badly; back, shoulders, neck and arms hurt badly; neck and arms hurt badly; arms hurt badly; Felt like I had to vomit but couldn't; No taste of food; No appetite; Headache; Dizziness; Coughing; This is a spontaneous report from a contactable consumer, the patient. A 68-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 24Mar2021 at 14:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetic, shellfish allergy and COVID-19. Concomitant medication included paracetamol (TYLENOL A) for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in the left arm on 03Mar2021 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 03:00, the patient slept 24 hours off and on and also experienced knees, back, shoulders, neck and arms hurt badly. The patient felt like she had to vomit but couldn't and also experienced no taste of food, no appetite, headache, dizziness and coughing. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events slept 24 hours off and on, knees, back, shoulders, neck and arms hurt badly, felt like to vomit, no taste of food, no appetite, headache, dizziness and coughing was recovered after 3 and half days.  No follow-up attempts are needed. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Poor quality sleep, Retching
Clinical narrative: Slept 24 hours off and on; Slept 24 hours off and on; knees, back, shoulders, neck and arms hurt badly; back, shoulders, neck and arms hurt badly; neck and arms hurt badly; arms hurt badly; Felt like I had to vomit but couldn't; No taste of food; No appetite; Headache; Dizziness; Coughing; This is a spontaneous report from a contactable consumer, the patient. A 68-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in the left arm on 24Mar2021 at 14:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetic, shellfish allergy and COVID-19. Concomitant medication included paracetamol (TYLENOL A) for an unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202) via an unspecified route of administration in the left arm on 03Mar2021 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 03:00, the patient slept 24 hours off and on and also experienced knees, back, shoulders, neck and arms hurt badly. The patient felt like she had to vomit but couldn't and also experienced no taste of food, no appetite, headache, dizziness and coughing. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events slept 24 hours off and on, knees, back, shoulders, neck and arms hurt badly, felt like to vomit, no taste of food, no appetite, headache, dizziness and coughing was recovered after 3 and half days.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 31Mar2021 at 10:45 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not received any other medications with in 2 weeks of COVID-19 vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 10Mar2021 at 11:30 as single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks, prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. The patient experienced swollen lymph nodes on 01Apr2021 at 17:00 . The patient did not receive any treatment for the reported event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swollen lymph nodes was recovering.   No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Insomnia
Clinical narrative: Exhaustion; Extreme insomnia; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration in the left arm on 29Mar2021 at 12:45 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included irritable bowel syndrome, post-traumatic stress disorder and IgA deficient. Patient had allergies to cephalosporin (MANUFACTURER UNKNOWN) class of antibiotics. Concomitant medications included vilazodone hydrochloride (VIIBRYD), topiramate (TOPAMAX), cetirizine hydrochloride (ZYRTEC), vitamin D6 (MANUFACTURER UNKNOWN), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate and dexamfetamine sulfate (ADDERALL). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient had not received any other vaccine within four weeks prior to the vaccination. On 29Mar2021 at 22:00, the patient experienced exhaustion. And on an unknown date in Mar2021, the patient experienced extreme insomnia. It was reported as day 1- the patient experienced exhaustion and days following-extreme insomnia. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measure was taken as a result of the events. The clinical outcome of the events exhaustion and extreme insomnia was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Muscle strain, Neck pain, Respiration abnormal
Clinical narrative: Pulled muscle; Even hurts to take a deep breath; I startedhaving a pain from the right side of myneck; startedhaving a pain from the right side of myneck, down over and around myshoulder blade; startedhaving a pain from the right side of myneck, down over and around myshoulder blade to mid-back.; This is a spontaneous report from a contactable consumer, the patient. A 58-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8734) via an unspecified route of administration in the arm left on 30Mar2021 at 10:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient included chronic neck issues, osteoarthritis and kiwi fruit allergy, left shoulder bursitis from an unspecified date.  The patient received other medications in two weeks which included cetirizine hydrochloride (MANUFACTURER UNKNOWN), collagen (MANUFACTURER UNKNOWN), enzymes (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. The patient previously received steroid (MANAFACTURER UNKNOWN) on an unspecified date for shoulder bursitis. Had a steroid shot several weeks ago for bursitis in left shoulder. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021 at 11:45 the patient experienced a pain from the right side of neck, down over and around shoulder blade to mid-back. It feels like a pulled muscle. It had progressively gotten worse over the past three days since the vaccine. It even hurt to take a deep breath. The patient stated that it may be neurological, and if it gets much worse, she'll need to go to the doctor. She was not positive this was related to the vaccine, but it was very coincidental if it was not. The patient did not receive any treatment for events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of pulled muscle, abnormal breathing, neck pain, shoulder blade pain, back pain was not recovered at the time of reporting.   No follow-up attempts are needed; No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Headache, Malaise
Clinical narrative: extreme fatigue; malaise; chills; fever; nausea; diarrhea; muscle aches; headaches; This is a spontaneous report from a contactable physician, the patient. A 43-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8727) via an unspecified route of administration in the left arm on 28Mar2021 at 11:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 28Mar2021, the patient experienced one week of extreme fatigue, malaise, chills, fever, nausea, diarrhea, muscle aches and headaches. No therapeutic measures were taken as a result of the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, malaise, chills, fever, nausea, headaches, diarrhea and muscle aches was not recovered at the time of this report.     No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: extreme fatigue; malaise; chills; fever; nausea; diarrhea; muscle aches; headaches; This is a spontaneous report from a contactable physician, the patient. A 43-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8727) via an unspecified route of administration in the left arm on 28Mar2021 at 11:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 28Mar2021, the patient experienced one week of extreme fatigue, malaise, chills, fever, nausea, diarrhea, muscle aches and headaches. No therapeutic measures were taken as a result of the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, malaise, chills, fever, nausea, headaches, diarrhea and muscle aches was not recovered at the time of this report.     No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea
Clinical narrative: Nausea; Headache; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 10:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medication included sertraline hydrochloride (ZOLOFT) for unknown indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 31Mar2021 at 06:00, the patient experienced nausea, headache and fatigue. The events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events nausea, headache and fatigue. The clinical outcomes of the events nausea, headache and fatigue were resolved on an unknown date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain
Clinical narrative: Headache; body ache; nauseous; This is a spontaneous report from a contactable consumer, the patient. A 63-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8733) via an unspecified route of administration in the left arm on 31Mar2021 at 14:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had a history of allergy to sulphate. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 08:00, the patient experienced headache, body ache, nauseous and also in bed for entire day after the second dose of vaccination. The adverse event did not result in doctor or other healthcare professional office/ clinic visit/ emergency room/ department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events headache, body ache and nauseous were resolved with sequelae on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Pyrexia
Clinical narrative: Headaches; low fever; Tiredness; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A non-pregnant female patient of an adult age group received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 26Mar2021 at 12:15, as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, asthma, anxiety and attention deficit hyperactivity disorder (ADHD). The patient was not allergic to medications, food, or other products. Concomitant medications included levothyroxine sodium (LEVOTHYROXINE) and sertraline (SETRALINE). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 05Mar2021 at 12:15, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks, prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021 at 18:00, the patient experienced headaches, low fever, tiredness and diarrhea. The patient did not receive any treatment for the reported events. The events did not result in a doctor or other healthcare professional office/clinic visit. The clinical outcome of the events headaches, low fever, tiredness and diarrhea were resolved at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: muscle aches; chills; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 31Mar2021 at 13:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient did not have any allergies to food, medications, or other products. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 01Apr2021 at 03:00, the patient experienced muscle aches and chills. The events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events muscle aches and chills. The clinical outcomes of the events muscle aches and chills were resolved in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash macular
Clinical narrative: Large cluster of red/purplespeckles.; Spots on my right thigh; This is a spontaneous report from a contactable consumer, the patient. A 22-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 11:15 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history included epstein-barr and pectus excavatum (her sunken chest puts pressure on her heart and lungs) from an unspecified date. The patient did not receive any other medications in two weeks of receiving the COVID-19 vaccine. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 13:00, the patient experienced a large cluster of red/purple speckles and spots on her right thigh (one week after first dose of vaccine). Therapeutic measures and treatments were not taken for the reported adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of red rash, spot like rash was not recovered at the time of reporting.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: consistent diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: Unknown) via an unspecified route of administration in the right arm on 01Apr2021 at 08:45 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 10:00, about 1 hour after the vaccination, the patient began having consistent diarrhoea that lasted approximately 12 hours, otherwise, the patient had no other adverse effects. No therapeutic measures were taken as a result of the event. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and the emergency room/department or urgent care. The clinical outcome of the event diarrhoea was recovered on 01Apr2021.   No follow-up attempts are needed; information about the lot number cannot be obtained.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: Loss of taste (50%); This is a spontaneous report from a contactable consumer, the patient. A 63-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 30Mar2021 at 14:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient was allergic to airborne allergies. The patient did not receive any other medications within two weeks prior to the COVID-19 vaccine. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 09Mar2021 at 14:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021at 16:00, two hours after vaccination, the patient experienced fifty percent loss of taste. The patient did not receive any treatment for the reported adverse event. The adverse events neither resulted in doctor or other healthcare professional office/clinic visit nor emergency room/department or urgent care. On 31Mar2021, in the morning, the event fifty percent loss of taste was resolved.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Abnormal dreams, Arthralgia, Back pain, Chills, Eye pain
Clinical narrative: Sore arm at the injection site; Achy back, joints, eyeballs; Achy back, joints, eyeballs; Achy back, joints, eyeballs; Weird dreams; Headache; Chills; Extreme exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 42-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 15:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy with raw shrimp. Patient did not receive any other medications in two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Mar2021 at 16:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 16:45, the patient experienced sore arm at the injection site, achy back, joints, eyeballs, weird dreams, headache, chills and extreme exhaustion. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of ore arm at the injection site, achy back, joints, eyeballs, weird dreams, headache, chills and extreme exhaustion was not resolved at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vaccination site pain
Clinical narrative: Sore arm at the injection site; Achy back, joints, eyeballs; Achy back, joints, eyeballs; Achy back, joints, eyeballs; Weird dreams; Headache; Chills; Extreme exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 42-years-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 15:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy with raw shrimp. Patient did not receive any other medications in two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 04Mar2021 at 16:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Apr2021 at 16:45, the patient experienced sore arm at the injection site, achy back, joints, eyeballs, weird dreams, headache, chills and extreme exhaustion. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of ore arm at the injection site, achy back, joints, eyeballs, weird dreams, headache, chills and extreme exhaustion was not resolved at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination site pain
Clinical narrative: Some nausea 2 days after; Soreness at injection site; This is a spontaneous report from a contactable consumer, the patient. A 38-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the arm left on 31Mar2021 at 12:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. Concomitant medications included escitalopram oxalate (LEXAPRO)  and amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) for unknown indication, from an unspecified date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 14:00 hours the patient experienced soreness at injection site.  On 02Apr2021, (2 days after vaccine) the patient experienced some nausea. No therapeutic measures were taken for the reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events soreness at injection site, some nausea were recovering.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site rash
Clinical narrative: Small rash on injection site; Enlarged lymph sub clavicular lymph node left side; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9810) via an unspecified route of administration in the left arm on 30Mar2021 at 14:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies. Concomitant medications included probiotics (MANUFACTURER UNKNOWN) and omeprazole (JUICE PLUS OMEGA) for unknown indication from unknown date received within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 09Mar2021 at 15:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had known allergies to several medications, food, or other products. On 01Apr2021 at 13:00, the patient experienced small rash on injection site and enlarged lymph sub clavicular lymph node left side. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the events vaccination site rash and sub clavicular lymphadenopathy was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.